Evaluating the neuroprotective impact of senolytic drugs on human vision

Nevin W. El-Nimri, Spencer M. Moore, Linda M. Zangwill, James A. Proudfoot, Robert N. Weinreb, Dorota Skowronska-Krawczyk, Sally L. Baxter
doi: https://doi.org/10.1101/2020.07.27.20163097

Article usage

Article usage: July 2020 to June 2025

AbstractFullPdf
Jul 2020136023
Aug 2020280072
Sep 202081068
Oct 202099072
Nov 2020147059
Dec 2020409230
Jan 202165314
Feb 202176116
Mar 2021731715
Apr 202194814
May 202165411
Jun 202146815
Jul 202141614
Aug 202149119
Sep 202135211
Oct 202141912
Nov 2021311121
Dec 20212498
Jan 20222069
Feb 20222003
Mar 202236211
Apr 20221425
May 202220210
Jun 20222704
Jul 20221402
Aug 20222124
Sep 20223429
Oct 20222607
Nov 20221507
Dec 20221326
Jan 20231645
Feb 20231454
Mar 20231125
Apr 20232313
May 20231018
Jun 20231247
Jul 2023805
Aug 2023161411
Sep 20231242
Oct 2023700
Nov 2023811
Dec 20231022
Jan 2024911
Feb 20241104
Mar 202410210
Apr 2024151010
May 2024741
Jun 20241653
Jul 20241725
Aug 20241242
Sep 20242558
Oct 202420129
Nov 20241229
Dec 2024905
Jan 20251328
Feb 202581612
Mar 202516339
Apr 20251849
May 2025212015
Jun 2025301
Back to top
Posted November 25, 2020.
Download PDF
Data/Code
Email
Evaluating the neuroprotective impact of senolytic drugs on human vision
Nevin W. El-Nimri, Spencer M. Moore, Linda M. Zangwill, James A. Proudfoot, Robert N. Weinreb, Dorota Skowronska-Krawczyk, Sally L. Baxter
medRxiv 2020.07.27.20163097; doi: https://doi.org/10.1101/2020.07.27.20163097
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area